Jean Emmanuel Sarry
Overview
Explore the profile of Jean Emmanuel Sarry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
467
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Birsen R, Larrue C, Decroocq J, Johnson N, Guiraud N, Gotanegre M, et al.
Haematologica
. 2021 Jan;
107(2):403-416.
PMID: 33406814
APR-246 is a promising new therapeutic agent that targets p53 mutated proteins in myelodysplastic syndromes and in acute myeloid leukemia (AML). APR-246 reactivates the transcriptional activity of p53 mutants by...
2.
Bertoli S, Paubelle E, Berard E, Saland E, Thomas X, Tavitian S, et al.
Eur J Haematol
. 2018 Oct;
102(2):131-142.
PMID: 30325535
Objectives: We previously reported the prognostic value of serum ferritin in younger patients with intermediate-risk acute myeloid leukemia (AML). The aims of this study were to confirm this finding in...
3.
Bertoli S, Picard M, Berard E, Griessinger E, Larrue C, Mouchel P, et al.
Haematologica
. 2018 Mar;
103(6):988-998.
PMID: 29519869
Patients with acute myeloid leukemia and a high white blood cell count are at increased risk of early death and relapse. Because mediators of inflammation contribute to leukostasis and chemoresistance,...
4.
Larrue C, Saland E, Boutzen H, Vergez F, David M, Joffre C, et al.
Blood
. 2015 Aug;
127(7):882-92.
PMID: 26286850
Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML) and is associated with a poor outcome....
5.
Larrue C, Saland E, Vergez F, Serhan N, Delabesse E, Mas V, et al.
Mol Cancer Ther
. 2015 Jul;
14(10):2364-73.
PMID: 26206337
We assessed the antileukemic activity of 2-deoxy-d-glucose (2-DG) through the modulation of expression of receptor tyrosine kinases (RTK) commonly mutated in acute myeloid leukemia (AML). We used human leukemic cell...
6.
Jacque N, Ronchetti A, Larrue C, Meunier G, Birsen R, Willems L, et al.
Blood
. 2015 Jul;
126(11):1346-56.
PMID: 26186940
Cancer cells require glutamine to adapt to increased biosynthetic activity. The limiting step in intracellular glutamine catabolism involves its conversion to glutamate by glutaminase (GA). Different GA isoforms are encoded...